Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionArjuna Capital
Latest Disclosed Ownership27,009 shares
Latest Disclosed Value $ 4,125,625
Arjuna Capital reports 9.33% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 6, 2026 - Arjuna Capital filed a 13F-HR form disclosing ownership of 27,009 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $4,125,625 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 24,705 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 9.33% during the quarter. The current value of the position is $4,008,136 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 27,009 2,304 9.33 4,126 21.11 1.0490
2026-02-05 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 24,705 -146 -0.59 3,406 6.91 0.8345
2025-11-04 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 24,851 12,959 108.97 3,187 121.40 0.7921
2025-08-13 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 11,892 -555 -4.46 1,439 3.75 0.3793
2025-05-09 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 12,447 -659 -5.03 1,388 8.78 0.3841
2025-02-07 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 13,106 -198 -1.49 1,275 -16.67 0.3394
2024-11-05 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 13,304 69 0.52 1,530 8.66 0.3963
2024-07-29 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 13,235 31 0.23 1,409 10.26 0.3791
2024-05-13 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,204 -9,927 -42.92 1,277 -45.31 0.3621
2024-02-08 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 23,131 1,068 4.84 2,336 3.92 0.7310
2023-11-09 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 22,063 22,063 2,247 0.8050
2022-02-11 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -9,782 -100.00 0 -100.00
2021-11-08 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,782 -170 -1.71 800 -11.89 0.3251
2021-08-11 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,952 222 2.28 908 9.13 0.3925
2021-05-11 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 9,730 437 4.70 832 -5.24 0.4091
2021-02-09 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 9,293 477 5.41 878 14.47 0.4860
2020-11-05 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,816 142 1.64 767 1.19 0.4760
2020-08-13 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,674 187 2.20 758 8.29 0.5229
2020-05-11 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,487 8,487 700 0.5840
2019-08-20 2019-06-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 0 -17,150 -100.00 0 -100.00
2019-05-14 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 17,150 277 1.64 1,649 13.88 1.2750
2019-01-31 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 16,873 -333 -1.94 1,448 -2.29 1.3188
2018-11-14 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 17,206 -174 -1.00 1,482 12.87 1.1149
2018-08-01 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 17,380 -1,394 -7.43 1,313 -13.50 1.0699
2018-04-24 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 18,774 263 1.42 1,518 -2.32 1.2804
2018-02-09 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 18,511 18,511 1,554 1.4551
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.